Clinical trial
Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus…
NCT00010400 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00010400 |
|---|---|
| Title | Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome |
| Lead sponsor | Johns Hopkins University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, filgrastim |
| Enrollment | 35 |
| Start date | Apr 1, 1997 |
| First posted | Feb 2, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: